nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2D6—Carteolol—glaucoma	0.0761	0.111	CbGbCtD
Loratadine—CYP2D6—Betaxolol—glaucoma	0.0514	0.0752	CbGbCtD
Loratadine—CYP2C19—Methazolamide—glaucoma	0.0513	0.075	CbGbCtD
Loratadine—CYP2C9—Diclofenamide—glaucoma	0.0495	0.0724	CbGbCtD
Loratadine—CYP2C9—Dorzolamide—glaucoma	0.0478	0.07	CbGbCtD
Loratadine—CYP2C19—Timolol—glaucoma	0.0436	0.0638	CbGbCtD
Loratadine—CYP2C9—Methazolamide—glaucoma	0.0426	0.0624	CbGbCtD
Loratadine—CYP2D6—Methazolamide—glaucoma	0.039	0.057	CbGbCtD
Loratadine—CYP3A4—Pilocarpine—glaucoma	0.0367	0.0537	CbGbCtD
Loratadine—ABCB1—Timolol—glaucoma	0.0352	0.0515	CbGbCtD
Loratadine—CYP2D6—Timolol—glaucoma	0.0331	0.0485	CbGbCtD
Loratadine—ABCB1—Clonidine—glaucoma	0.0299	0.0437	CbGbCtD
Loratadine—CYP3A4—Brinzolamide—glaucoma	0.0288	0.0421	CbGbCtD
Loratadine—CYP2D6—Clonidine—glaucoma	0.0282	0.0412	CbGbCtD
Loratadine—CYP3A4—Dorzolamide—glaucoma	0.0278	0.0407	CbGbCtD
Loratadine—CYP3A4—Methazolamide—glaucoma	0.0248	0.0363	CbGbCtD
Loratadine—CYP3A4—Acetazolamide—glaucoma	0.0198	0.029	CbGbCtD
Loratadine—CYP3A4—Clonidine—glaucoma	0.0179	0.0262	CbGbCtD
Loratadine—Rash—Latanoprost—glaucoma	0.000466	0.00148	CcSEcCtD
Loratadine—Dermatitis—Latanoprost—glaucoma	0.000466	0.00148	CcSEcCtD
Loratadine—Dyspepsia—Acetazolamide—glaucoma	0.000466	0.00148	CcSEcCtD
Loratadine—Tachycardia—Brinzolamide—glaucoma	0.000465	0.00148	CcSEcCtD
Loratadine—Headache—Latanoprost—glaucoma	0.000463	0.00147	CcSEcCtD
Loratadine—Skin disorder—Brinzolamide—glaucoma	0.000463	0.00147	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000462	0.00147	CcSEcCtD
Loratadine—Arrhythmia—Clonidine—glaucoma	0.00046	0.00146	CcSEcCtD
Loratadine—Insomnia—Brimonidine—glaucoma	0.000459	0.00146	CcSEcCtD
Loratadine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000457	0.00145	CcSEcCtD
Loratadine—Fatigue—Acetazolamide—glaucoma	0.000456	0.00145	CcSEcCtD
Loratadine—Paraesthesia—Brimonidine—glaucoma	0.000456	0.00145	CcSEcCtD
Loratadine—Alopecia—Clonidine—glaucoma	0.000455	0.00144	CcSEcCtD
Loratadine—Nausea—Methazolamide—glaucoma	0.000454	0.00144	CcSEcCtD
Loratadine—Hypotension—Dorzolamide—glaucoma	0.000453	0.00144	CcSEcCtD
Loratadine—Somnolence—Brimonidine—glaucoma	0.000451	0.00143	CcSEcCtD
Loratadine—Hypotension—Travoprost—glaucoma	0.000451	0.00143	CcSEcCtD
Loratadine—Shock—Pilocarpine—glaucoma	0.000451	0.00143	CcSEcCtD
Loratadine—Tachycardia—Pilocarpine—glaucoma	0.000447	0.00142	CcSEcCtD
Loratadine—Dyspepsia—Brimonidine—glaucoma	0.000447	0.00142	CcSEcCtD
Loratadine—Hypotension—Brinzolamide—glaucoma	0.000445	0.00141	CcSEcCtD
Loratadine—Pharyngitis—Betaxolol—glaucoma	0.000445	0.00141	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000442	0.0014	CcSEcCtD
Loratadine—Tension—Clonidine—glaucoma	0.00044	0.0014	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Travoprost—glaucoma	0.00044	0.0014	CcSEcCtD
Loratadine—Insomnia—Dorzolamide—glaucoma	0.000438	0.00139	CcSEcCtD
Loratadine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000438	0.00139	CcSEcCtD
Loratadine—Fatigue—Brimonidine—glaucoma	0.000438	0.00139	CcSEcCtD
Loratadine—Feeling abnormal—Acetazolamide—glaucoma	0.000436	0.00138	CcSEcCtD
Loratadine—Nervousness—Clonidine—glaucoma	0.000435	0.00138	CcSEcCtD
Loratadine—Paraesthesia—Dorzolamide—glaucoma	0.000435	0.00138	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000434	0.00138	CcSEcCtD
Loratadine—Pain—Brimonidine—glaucoma	0.000434	0.00138	CcSEcCtD
Loratadine—Insomnia—Brinzolamide—glaucoma	0.000431	0.00137	CcSEcCtD
Loratadine—Somnolence—Dorzolamide—glaucoma	0.000431	0.00137	CcSEcCtD
Loratadine—Hypotension—Pilocarpine—glaucoma	0.000428	0.00136	CcSEcCtD
Loratadine—Paraesthesia—Brinzolamide—glaucoma	0.000428	0.00136	CcSEcCtD
Loratadine—Dyspepsia—Dorzolamide—glaucoma	0.000427	0.00135	CcSEcCtD
Loratadine—Dyspepsia—Travoprost—glaucoma	0.000425	0.00135	CcSEcCtD
Loratadine—Asthenia—Apraclonidine—glaucoma	0.000424	0.00135	CcSEcCtD
Loratadine—Somnolence—Brinzolamide—glaucoma	0.000424	0.00134	CcSEcCtD
Loratadine—Dyspepsia—Brinzolamide—glaucoma	0.00042	0.00133	CcSEcCtD
Loratadine—Body temperature increased—Acetazolamide—glaucoma	0.000418	0.00133	CcSEcCtD
Loratadine—Fatigue—Dorzolamide—glaucoma	0.000418	0.00133	CcSEcCtD
Loratadine—Tinnitus—Betaxolol—glaucoma	0.000418	0.00133	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000417	0.00132	CcSEcCtD
Loratadine—Gastrointestinal disorder—Travoprost—glaucoma	0.000417	0.00132	CcSEcCtD
Loratadine—Fatigue—Travoprost—glaucoma	0.000416	0.00132	CcSEcCtD
Loratadine—Ill-defined disorder—Clonidine—glaucoma	0.000416	0.00132	CcSEcCtD
Loratadine—Pain—Dorzolamide—glaucoma	0.000415	0.00132	CcSEcCtD
Loratadine—Insomnia—Pilocarpine—glaucoma	0.000414	0.00131	CcSEcCtD
Loratadine—Pain—Travoprost—glaucoma	0.000413	0.00131	CcSEcCtD
Loratadine—Constipation—Travoprost—glaucoma	0.000413	0.00131	CcSEcCtD
Loratadine—Agitation—Clonidine—glaucoma	0.000412	0.00131	CcSEcCtD
Loratadine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000411	0.00131	CcSEcCtD
Loratadine—Paraesthesia—Pilocarpine—glaucoma	0.000411	0.00131	CcSEcCtD
Loratadine—Asthenia—Bimatoprost—glaucoma	0.000411	0.00131	CcSEcCtD
Loratadine—Fatigue—Brinzolamide—glaucoma	0.000411	0.0013	CcSEcCtD
Loratadine—Angioedema—Clonidine—glaucoma	0.00041	0.0013	CcSEcCtD
Loratadine—Pain—Brinzolamide—glaucoma	0.000408	0.00129	CcSEcCtD
Loratadine—Somnolence—Pilocarpine—glaucoma	0.000407	0.00129	CcSEcCtD
Loratadine—Depression—Timolol—glaucoma	0.000407	0.00129	CcSEcCtD
Loratadine—Immune system disorder—Betaxolol—glaucoma	0.000405	0.00128	CcSEcCtD
Loratadine—Diarrhoea—Apraclonidine—glaucoma	0.000405	0.00128	CcSEcCtD
Loratadine—Malaise—Clonidine—glaucoma	0.000404	0.00128	CcSEcCtD
Loratadine—Dyspepsia—Pilocarpine—glaucoma	0.000403	0.00128	CcSEcCtD
Loratadine—Syncope—Clonidine—glaucoma	0.000402	0.00128	CcSEcCtD
Loratadine—Arrhythmia—Betaxolol—glaucoma	0.0004	0.00127	CcSEcCtD
Loratadine—Feeling abnormal—Dorzolamide—glaucoma	0.000399	0.00127	CcSEcCtD
Loratadine—Feeling abnormal—Travoprost—glaucoma	0.000398	0.00126	CcSEcCtD
Loratadine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000396	0.00126	CcSEcCtD
Loratadine—Alopecia—Betaxolol—glaucoma	0.000396	0.00126	CcSEcCtD
Loratadine—Palpitations—Clonidine—glaucoma	0.000396	0.00126	CcSEcCtD
Loratadine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000395	0.00126	CcSEcCtD
Loratadine—Gastrointestinal pain—Travoprost—glaucoma	0.000395	0.00125	CcSEcCtD
Loratadine—Loss of consciousness—Clonidine—glaucoma	0.000394	0.00125	CcSEcCtD
Loratadine—Feeling abnormal—Brinzolamide—glaucoma	0.000393	0.00125	CcSEcCtD
Loratadine—Constipation—Pilocarpine—glaucoma	0.000392	0.00124	CcSEcCtD
Loratadine—Pain—Pilocarpine—glaucoma	0.000392	0.00124	CcSEcCtD
Loratadine—Cough—Clonidine—glaucoma	0.000391	0.00124	CcSEcCtD
Loratadine—Dizziness—Apraclonidine—glaucoma	0.000391	0.00124	CcSEcCtD
Loratadine—Epistaxis—Timolol—glaucoma	0.000385	0.00122	CcSEcCtD
Loratadine—Body temperature increased—Dorzolamide—glaucoma	0.000383	0.00122	CcSEcCtD
Loratadine—Abdominal pain—Dorzolamide—glaucoma	0.000383	0.00122	CcSEcCtD
Loratadine—Tension—Betaxolol—glaucoma	0.000383	0.00122	CcSEcCtD
Loratadine—Dysgeusia—Betaxolol—glaucoma	0.000382	0.00121	CcSEcCtD
Loratadine—Chest pain—Clonidine—glaucoma	0.000382	0.00121	CcSEcCtD
Loratadine—Abdominal pain—Travoprost—glaucoma	0.000382	0.00121	CcSEcCtD
Loratadine—Asthenia—Acetazolamide—glaucoma	0.000379	0.0012	CcSEcCtD
Loratadine—Dizziness—Bimatoprost—glaucoma	0.000379	0.0012	CcSEcCtD
Loratadine—Nervousness—Betaxolol—glaucoma	0.000379	0.0012	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000379	0.0012	CcSEcCtD
Loratadine—Feeling abnormal—Pilocarpine—glaucoma	0.000377	0.0012	CcSEcCtD
Loratadine—Discomfort—Clonidine—glaucoma	0.000377	0.0012	CcSEcCtD
Loratadine—Vomiting—Apraclonidine—glaucoma	0.000376	0.00119	CcSEcCtD
Loratadine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000375	0.00119	CcSEcCtD
Loratadine—Dry mouth—Clonidine—glaucoma	0.000373	0.00118	CcSEcCtD
Loratadine—Dermatitis—Apraclonidine—glaucoma	0.000372	0.00118	CcSEcCtD
Loratadine—Headache—Apraclonidine—glaucoma	0.00037	0.00118	CcSEcCtD
Loratadine—Asthenia—Brimonidine—glaucoma	0.000364	0.00116	CcSEcCtD
Loratadine—Abdominal pain—Pilocarpine—glaucoma	0.000362	0.00115	CcSEcCtD
Loratadine—Body temperature increased—Pilocarpine—glaucoma	0.000362	0.00115	CcSEcCtD
Loratadine—Ill-defined disorder—Betaxolol—glaucoma	0.000362	0.00115	CcSEcCtD
Loratadine—Diarrhoea—Acetazolamide—glaucoma	0.000362	0.00115	CcSEcCtD
Loratadine—Rash—Bimatoprost—glaucoma	0.000361	0.00115	CcSEcCtD
Loratadine—Dermatitis—Bimatoprost—glaucoma	0.000361	0.00115	CcSEcCtD
Loratadine—Shock—Clonidine—glaucoma	0.00036	0.00114	CcSEcCtD
Loratadine—Headache—Bimatoprost—glaucoma	0.000359	0.00114	CcSEcCtD
Loratadine—Nervous system disorder—Clonidine—glaucoma	0.000359	0.00114	CcSEcCtD
Loratadine—Tachycardia—Clonidine—glaucoma	0.000357	0.00113	CcSEcCtD
Loratadine—Skin disorder—Clonidine—glaucoma	0.000355	0.00113	CcSEcCtD
Loratadine—Malaise—Betaxolol—glaucoma	0.000352	0.00112	CcSEcCtD
Loratadine—Nausea—Apraclonidine—glaucoma	0.000351	0.00111	CcSEcCtD
Loratadine—Syncope—Betaxolol—glaucoma	0.00035	0.00111	CcSEcCtD
Loratadine—Dizziness—Acetazolamide—glaucoma	0.00035	0.00111	CcSEcCtD
Loratadine—Asthenia—Dorzolamide—glaucoma	0.000348	0.0011	CcSEcCtD
Loratadine—Asthenia—Travoprost—glaucoma	0.000346	0.0011	CcSEcCtD
Loratadine—Palpitations—Betaxolol—glaucoma	0.000345	0.00109	CcSEcCtD
Loratadine—Loss of consciousness—Betaxolol—glaucoma	0.000343	0.00109	CcSEcCtD
Loratadine—Asthenia—Brinzolamide—glaucoma	0.000342	0.00109	CcSEcCtD
Loratadine—Hypotension—Clonidine—glaucoma	0.000342	0.00108	CcSEcCtD
Loratadine—Tinnitus—Timolol—glaucoma	0.000341	0.00108	CcSEcCtD
Loratadine—Cough—Betaxolol—glaucoma	0.000341	0.00108	CcSEcCtD
Loratadine—Nausea—Bimatoprost—glaucoma	0.000341	0.00108	CcSEcCtD
Loratadine—Vomiting—Acetazolamide—glaucoma	0.000336	0.00107	CcSEcCtD
Loratadine—Dizziness—Brimonidine—glaucoma	0.000336	0.00107	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000333	0.00106	CcSEcCtD
Loratadine—Chest pain—Betaxolol—glaucoma	0.000332	0.00105	CcSEcCtD
Loratadine—Myalgia—Betaxolol—glaucoma	0.000332	0.00105	CcSEcCtD
Loratadine—Diarrhoea—Dorzolamide—glaucoma	0.000332	0.00105	CcSEcCtD
Loratadine—Headache—Acetazolamide—glaucoma	0.000331	0.00105	CcSEcCtD
Loratadine—Insomnia—Clonidine—glaucoma	0.000331	0.00105	CcSEcCtD
Loratadine—Immune system disorder—Timolol—glaucoma	0.000331	0.00105	CcSEcCtD
Loratadine—Diarrhoea—Travoprost—glaucoma	0.00033	0.00105	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00033	0.00105	CcSEcCtD
Loratadine—Asthenia—Pilocarpine—glaucoma	0.000329	0.00104	CcSEcCtD
Loratadine—Paraesthesia—Clonidine—glaucoma	0.000328	0.00104	CcSEcCtD
Loratadine—Discomfort—Betaxolol—glaucoma	0.000328	0.00104	CcSEcCtD
Loratadine—Arrhythmia—Timolol—glaucoma	0.000327	0.00104	CcSEcCtD
Loratadine—Diarrhoea—Brinzolamide—glaucoma	0.000326	0.00103	CcSEcCtD
Loratadine—Somnolence—Clonidine—glaucoma	0.000325	0.00103	CcSEcCtD
Loratadine—Dry mouth—Betaxolol—glaucoma	0.000325	0.00103	CcSEcCtD
Loratadine—Alopecia—Timolol—glaucoma	0.000324	0.00103	CcSEcCtD
Loratadine—Dizziness—Dorzolamide—glaucoma	0.000321	0.00102	CcSEcCtD
Loratadine—Rash—Brimonidine—glaucoma	0.00032	0.00102	CcSEcCtD
Loratadine—Dermatitis—Brimonidine—glaucoma	0.00032	0.00101	CcSEcCtD
Loratadine—Dizziness—Travoprost—glaucoma	0.000319	0.00101	CcSEcCtD
Loratadine—Headache—Brimonidine—glaucoma	0.000318	0.00101	CcSEcCtD
Loratadine—Gastrointestinal disorder—Clonidine—glaucoma	0.000316	0.001	CcSEcCtD
Loratadine—Fatigue—Clonidine—glaucoma	0.000315	0.001	CcSEcCtD
Loratadine—Dizziness—Brinzolamide—glaucoma	0.000315	0.001	CcSEcCtD
Loratadine—Nausea—Acetazolamide—glaucoma	0.000314	0.000997	CcSEcCtD
Loratadine—Diarrhoea—Pilocarpine—glaucoma	0.000313	0.000995	CcSEcCtD
Loratadine—Shock—Betaxolol—glaucoma	0.000313	0.000994	CcSEcCtD
Loratadine—Tension—Timolol—glaucoma	0.000313	0.000993	CcSEcCtD
Loratadine—Pain—Clonidine—glaucoma	0.000313	0.000993	CcSEcCtD
Loratadine—Constipation—Clonidine—glaucoma	0.000313	0.000993	CcSEcCtD
Loratadine—Nervous system disorder—Betaxolol—glaucoma	0.000312	0.000991	CcSEcCtD
Loratadine—Dysgeusia—Timolol—glaucoma	0.000312	0.000991	CcSEcCtD
Loratadine—Tachycardia—Betaxolol—glaucoma	0.000311	0.000986	CcSEcCtD
Loratadine—Nervousness—Timolol—glaucoma	0.00031	0.000983	CcSEcCtD
Loratadine—Skin disorder—Betaxolol—glaucoma	0.000309	0.000982	CcSEcCtD
Loratadine—Vomiting—Dorzolamide—glaucoma	0.000308	0.000978	CcSEcCtD
Loratadine—Rash—Dorzolamide—glaucoma	0.000306	0.00097	CcSEcCtD
Loratadine—Dermatitis—Dorzolamide—glaucoma	0.000305	0.000969	CcSEcCtD
Loratadine—Rash—Travoprost—glaucoma	0.000304	0.000966	CcSEcCtD
Loratadine—Dermatitis—Travoprost—glaucoma	0.000304	0.000965	CcSEcCtD
Loratadine—Headache—Dorzolamide—glaucoma	0.000304	0.000964	CcSEcCtD
Loratadine—Vomiting—Brinzolamide—glaucoma	0.000303	0.000962	CcSEcCtD
Loratadine—Dizziness—Pilocarpine—glaucoma	0.000303	0.000961	CcSEcCtD
Loratadine—Headache—Travoprost—glaucoma	0.000302	0.00096	CcSEcCtD
Loratadine—Nausea—Brimonidine—glaucoma	0.000302	0.000957	CcSEcCtD
Loratadine—Feeling abnormal—Clonidine—glaucoma	0.000301	0.000957	CcSEcCtD
Loratadine—Rash—Brinzolamide—glaucoma	0.000301	0.000954	CcSEcCtD
Loratadine—Dermatitis—Brinzolamide—glaucoma	0.0003	0.000953	CcSEcCtD
Loratadine—Gastrointestinal pain—Clonidine—glaucoma	0.000299	0.000949	CcSEcCtD
Loratadine—Headache—Brinzolamide—glaucoma	0.000299	0.000948	CcSEcCtD
Loratadine—Hypotension—Betaxolol—glaucoma	0.000298	0.000944	CcSEcCtD
Loratadine—Angioedema—Timolol—glaucoma	0.000291	0.000924	CcSEcCtD
Loratadine—Vomiting—Pilocarpine—glaucoma	0.000291	0.000924	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00029	0.000921	CcSEcCtD
Loratadine—Abdominal pain—Clonidine—glaucoma	0.000289	0.000918	CcSEcCtD
Loratadine—Body temperature increased—Clonidine—glaucoma	0.000289	0.000918	CcSEcCtD
Loratadine—Rash—Pilocarpine—glaucoma	0.000289	0.000917	CcSEcCtD
Loratadine—Dermatitis—Pilocarpine—glaucoma	0.000289	0.000916	CcSEcCtD
Loratadine—Insomnia—Betaxolol—glaucoma	0.000288	0.000914	CcSEcCtD
Loratadine—Nausea—Dorzolamide—glaucoma	0.000288	0.000914	CcSEcCtD
Loratadine—Headache—Pilocarpine—glaucoma	0.000287	0.000911	CcSEcCtD
Loratadine—Nausea—Travoprost—glaucoma	0.000287	0.00091	CcSEcCtD
Loratadine—Paraesthesia—Betaxolol—glaucoma	0.000286	0.000908	CcSEcCtD
Loratadine—Syncope—Timolol—glaucoma	0.000286	0.000907	CcSEcCtD
Loratadine—Nausea—Brinzolamide—glaucoma	0.000283	0.000898	CcSEcCtD
Loratadine—Palpitations—Timolol—glaucoma	0.000282	0.000894	CcSEcCtD
Loratadine—Dyspepsia—Betaxolol—glaucoma	0.00028	0.00089	CcSEcCtD
Loratadine—Loss of consciousness—Timolol—glaucoma	0.00028	0.000889	CcSEcCtD
Loratadine—Cough—Timolol—glaucoma	0.000278	0.000883	CcSEcCtD
Loratadine—Hypertension—Timolol—glaucoma	0.000275	0.000873	CcSEcCtD
Loratadine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000275	0.000873	CcSEcCtD
Loratadine—Fatigue—Betaxolol—glaucoma	0.000275	0.000871	CcSEcCtD
Loratadine—Constipation—Betaxolol—glaucoma	0.000272	0.000864	CcSEcCtD
Loratadine—Pain—Betaxolol—glaucoma	0.000272	0.000864	CcSEcCtD
Loratadine—Nausea—Pilocarpine—glaucoma	0.000272	0.000864	CcSEcCtD
Loratadine—Chest pain—Timolol—glaucoma	0.000271	0.000861	CcSEcCtD
Loratadine—Myalgia—Timolol—glaucoma	0.000271	0.000861	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00027	0.000855	CcSEcCtD
Loratadine—Discomfort—Timolol—glaucoma	0.000268	0.000851	CcSEcCtD
Loratadine—Dry mouth—Timolol—glaucoma	0.000265	0.000842	CcSEcCtD
Loratadine—Asthenia—Clonidine—glaucoma	0.000262	0.000833	CcSEcCtD
Loratadine—Feeling abnormal—Betaxolol—glaucoma	0.000262	0.000833	CcSEcCtD
Loratadine—Anaphylactic shock—Timolol—glaucoma	0.00026	0.000826	CcSEcCtD
Loratadine—Shock—Timolol—glaucoma	0.000256	0.000812	CcSEcCtD
Loratadine—Nervous system disorder—Timolol—glaucoma	0.000255	0.00081	CcSEcCtD
Loratadine—Skin disorder—Timolol—glaucoma	0.000253	0.000802	CcSEcCtD
Loratadine—Body temperature increased—Betaxolol—glaucoma	0.000252	0.000799	CcSEcCtD
Loratadine—Diarrhoea—Clonidine—glaucoma	0.00025	0.000794	CcSEcCtD
Loratadine—Hypotension—Timolol—glaucoma	0.000243	0.000772	CcSEcCtD
Loratadine—Dizziness—Clonidine—glaucoma	0.000242	0.000768	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Timolol—glaucoma	0.000237	0.000752	CcSEcCtD
Loratadine—Insomnia—Timolol—glaucoma	0.000235	0.000747	CcSEcCtD
Loratadine—Paraesthesia—Timolol—glaucoma	0.000234	0.000741	CcSEcCtD
Loratadine—Vomiting—Clonidine—glaucoma	0.000233	0.000738	CcSEcCtD
Loratadine—Somnolence—Timolol—glaucoma	0.000231	0.000734	CcSEcCtD
Loratadine—Rash—Clonidine—glaucoma	0.000231	0.000732	CcSEcCtD
Loratadine—Dermatitis—Clonidine—glaucoma	0.00023	0.000731	CcSEcCtD
Loratadine—Headache—Clonidine—glaucoma	0.000229	0.000727	CcSEcCtD
Loratadine—Dyspepsia—Timolol—glaucoma	0.000229	0.000727	CcSEcCtD
Loratadine—Asthenia—Betaxolol—glaucoma	0.000228	0.000725	CcSEcCtD
Loratadine—Gastrointestinal disorder—Timolol—glaucoma	0.000225	0.000713	CcSEcCtD
Loratadine—Fatigue—Timolol—glaucoma	0.000224	0.000712	CcSEcCtD
Loratadine—Pain—Timolol—glaucoma	0.000222	0.000706	CcSEcCtD
Loratadine—Diarrhoea—Betaxolol—glaucoma	0.000218	0.000692	CcSEcCtD
Loratadine—Nausea—Clonidine—glaucoma	0.000217	0.00069	CcSEcCtD
Loratadine—Feeling abnormal—Timolol—glaucoma	0.000214	0.00068	CcSEcCtD
Loratadine—Gastrointestinal pain—Timolol—glaucoma	0.000213	0.000675	CcSEcCtD
Loratadine—Dizziness—Betaxolol—glaucoma	0.000211	0.000668	CcSEcCtD
Loratadine—Abdominal pain—Timolol—glaucoma	0.000206	0.000653	CcSEcCtD
Loratadine—Body temperature increased—Timolol—glaucoma	0.000206	0.000653	CcSEcCtD
Loratadine—Vomiting—Betaxolol—glaucoma	0.000202	0.000643	CcSEcCtD
Loratadine—Rash—Betaxolol—glaucoma	0.000201	0.000637	CcSEcCtD
Loratadine—Dermatitis—Betaxolol—glaucoma	0.000201	0.000637	CcSEcCtD
Loratadine—Headache—Betaxolol—glaucoma	0.0002	0.000633	CcSEcCtD
Loratadine—Nausea—Betaxolol—glaucoma	0.000189	0.0006	CcSEcCtD
Loratadine—Asthenia—Timolol—glaucoma	0.000187	0.000592	CcSEcCtD
Loratadine—Diarrhoea—Timolol—glaucoma	0.000178	0.000565	CcSEcCtD
Loratadine—Dizziness—Timolol—glaucoma	0.000172	0.000546	CcSEcCtD
Loratadine—Vomiting—Timolol—glaucoma	0.000165	0.000525	CcSEcCtD
Loratadine—Rash—Timolol—glaucoma	0.000164	0.000521	CcSEcCtD
Loratadine—Dermatitis—Timolol—glaucoma	0.000164	0.00052	CcSEcCtD
Loratadine—Headache—Timolol—glaucoma	0.000163	0.000517	CcSEcCtD
Loratadine—Nausea—Timolol—glaucoma	0.000155	0.00049	CcSEcCtD
Loratadine—HRH1—G alpha (q) signalling events—OPN4—glaucoma	1.28e-05	0.0105	CbGpPWpGaD
Loratadine—KCNH2—Neuronal System—SLC6A13—glaucoma	1.26e-05	0.0102	CbGpPWpGaD
Loratadine—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	1.25e-05	0.0102	CbGpPWpGaD
Loratadine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	1.2e-05	0.00978	CbGpPWpGaD
Loratadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	1.17e-05	0.00954	CbGpPWpGaD
Loratadine—HRH1—G alpha (q) signalling events—PTGFR—glaucoma	1.15e-05	0.00941	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	1.15e-05	0.00935	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—NTRK2—glaucoma	1.14e-05	0.00928	CbGpPWpGaD
Loratadine—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	1.1e-05	0.00898	CbGpPWpGaD
Loratadine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	1.09e-05	0.00891	CbGpPWpGaD
Loratadine—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.08e-05	0.00884	CbGpPWpGaD
Loratadine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	1.06e-05	0.00864	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	1.03e-05	0.00842	CbGpPWpGaD
Loratadine—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	1.01e-05	0.00826	CbGpPWpGaD
Loratadine—HRH1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	9.91e-06	0.00808	CbGpPWpGaD
Loratadine—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	9.86e-06	0.00804	CbGpPWpGaD
Loratadine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	9.58e-06	0.00782	CbGpPWpGaD
Loratadine—KCNH2—Neuronal System—SLC6A1—glaucoma	9.19e-06	0.0075	CbGpPWpGaD
Loratadine—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	8.95e-06	0.0073	CbGpPWpGaD
Loratadine—HRH1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	8.92e-06	0.00728	CbGpPWpGaD
Loratadine—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	8.8e-06	0.00718	CbGpPWpGaD
Loratadine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.52e-06	0.00695	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—BDNF—glaucoma	8.49e-06	0.00693	CbGpPWpGaD
Loratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	8.49e-06	0.00692	CbGpPWpGaD
Loratadine—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.41e-06	0.00686	CbGpPWpGaD
Loratadine—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	8.23e-06	0.00672	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—IL1A—glaucoma	8.15e-06	0.00665	CbGpPWpGaD
Loratadine—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	8.03e-06	0.00655	CbGpPWpGaD
Loratadine—HRH1—IL-4 Signaling Pathway—BAD—glaucoma	7.85e-06	0.00641	CbGpPWpGaD
Loratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	7.64e-06	0.00623	CbGpPWpGaD
Loratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.61e-06	0.00621	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—NGF—glaucoma	7.54e-06	0.00615	CbGpPWpGaD
Loratadine—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.51e-06	0.00612	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—NR3C1—glaucoma	7.5e-06	0.00612	CbGpPWpGaD
Loratadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.21e-06	0.00588	CbGpPWpGaD
Loratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7e-06	0.00571	CbGpPWpGaD
Loratadine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.94e-06	0.00566	CbGpPWpGaD
Loratadine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.91e-06	0.00564	CbGpPWpGaD
Loratadine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.91e-06	0.00563	CbGpPWpGaD
Loratadine—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.85e-06	0.00558	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—OPN4—glaucoma	6.46e-06	0.00527	CbGpPWpGaD
Loratadine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.17e-06	0.00503	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—PTGFR—glaucoma	5.82e-06	0.00475	CbGpPWpGaD
Loratadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.67e-06	0.00463	CbGpPWpGaD
Loratadine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	5.66e-06	0.00462	CbGpPWpGaD
Loratadine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.62e-06	0.00459	CbGpPWpGaD
Loratadine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	5.57e-06	0.00454	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	5.11e-06	0.00417	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—IL1A—glaucoma	4.79e-06	0.00391	CbGpPWpGaD
Loratadine—CYP2C8—Biological oxidations—GSTT1—glaucoma	4.61e-06	0.00376	CbGpPWpGaD
Loratadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.58e-06	0.00373	CbGpPWpGaD
Loratadine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.52e-06	0.00368	CbGpPWpGaD
Loratadine—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	4.45e-06	0.00363	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—FAS—glaucoma	4.27e-06	0.00348	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—C3—glaucoma	4.21e-06	0.00343	CbGpPWpGaD
Loratadine—CYP2C19—Biological oxidations—GSTT1—glaucoma	4.11e-06	0.00335	CbGpPWpGaD
Loratadine—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	3.97e-06	0.00324	CbGpPWpGaD
Loratadine—HRH1—G alpha (q) signalling events—EDN1—glaucoma	3.84e-06	0.00313	CbGpPWpGaD
Loratadine—CYP2D6—Biological oxidations—GSTT1—glaucoma	3.78e-06	0.00308	CbGpPWpGaD
Loratadine—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.75e-06	0.00306	CbGpPWpGaD
Loratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	3.73e-06	0.00304	CbGpPWpGaD
Loratadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.71e-06	0.00303	CbGpPWpGaD
Loratadine—CYP2C8—Biological oxidations—CYP1B1—glaucoma	3.67e-06	0.00299	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—OPN4—glaucoma	3.65e-06	0.00298	CbGpPWpGaD
Loratadine—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	3.62e-06	0.00295	CbGpPWpGaD
Loratadine—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	3.62e-06	0.00295	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	3.61e-06	0.00294	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.6e-06	0.00294	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.45e-06	0.00281	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.43e-06	0.0028	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.43e-06	0.0028	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—OPN4—glaucoma	3.32e-06	0.00271	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PTGFR—glaucoma	3.29e-06	0.00268	CbGpPWpGaD
Loratadine—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.28e-06	0.00267	CbGpPWpGaD
Loratadine—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.23e-06	0.00264	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NARFL—glaucoma	3.23e-06	0.00263	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CA5A—glaucoma	3.23e-06	0.00263	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—TNF—glaucoma	3.09e-06	0.00252	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.06e-06	0.0025	CbGpPWpGaD
Loratadine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.01e-06	0.00246	CbGpPWpGaD
Loratadine—CYP2C9—Biological oxidations—CYP1B1—glaucoma	2.99e-06	0.00244	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PTGFR—glaucoma	2.99e-06	0.00244	CbGpPWpGaD
Loratadine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.97e-06	0.00242	CbGpPWpGaD
Loratadine—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	2.95e-06	0.0024	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—SMO—glaucoma	2.94e-06	0.00239	CbGpPWpGaD
Loratadine—CYP2C8—Biological oxidations—GSTM1—glaucoma	2.93e-06	0.00239	CbGpPWpGaD
Loratadine—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	2.89e-06	0.00236	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CA5A—glaucoma	2.88e-06	0.00235	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NARFL—glaucoma	2.88e-06	0.00235	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LRP12—glaucoma	2.83e-06	0.00231	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CA5A—glaucoma	2.81e-06	0.00229	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NARFL—glaucoma	2.81e-06	0.00229	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.79e-06	0.00228	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.69e-06	0.00219	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NARFL—glaucoma	2.65e-06	0.00216	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CA5A—glaucoma	2.65e-06	0.00216	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CA5A—glaucoma	2.63e-06	0.00214	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NARFL—glaucoma	2.63e-06	0.00214	CbGpPWpGaD
Loratadine—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.62e-06	0.00214	CbGpPWpGaD
Loratadine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.58e-06	0.00211	CbGpPWpGaD
Loratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.54e-06	0.00207	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.48e-06	0.00202	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.47e-06	0.00202	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.46e-06	0.00201	CbGpPWpGaD
Loratadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.44e-06	0.00199	CbGpPWpGaD
Loratadine—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.41e-06	0.00197	CbGpPWpGaD
Loratadine—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.39e-06	0.00195	CbGpPWpGaD
Loratadine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.38e-06	0.00194	CbGpPWpGaD
Loratadine—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.36e-06	0.00192	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.3e-06	0.00188	CbGpPWpGaD
Loratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.22e-06	0.00181	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.12e-06	0.00173	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.11e-06	0.00172	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.97e-06	0.00161	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—OPN4—glaucoma	1.96e-06	0.0016	CbGpPWpGaD
Loratadine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.94e-06	0.00158	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—EDN1—glaucoma	1.94e-06	0.00158	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HEYL—glaucoma	1.82e-06	0.00149	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—TNF—glaucoma	1.81e-06	0.00148	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.8e-06	0.00147	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTGFR—glaucoma	1.76e-06	0.00144	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NARFL—glaucoma	1.73e-06	0.00141	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CA5A—glaucoma	1.73e-06	0.00141	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—C3—glaucoma	1.69e-06	0.00138	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.68e-06	0.00137	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CA1—glaucoma	1.58e-06	0.00129	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.58e-06	0.00128	CbGpPWpGaD
Loratadine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.55e-06	0.00127	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CTSA—glaucoma	1.53e-06	0.00125	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—SMO—glaucoma	1.51e-06	0.00123	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CA2—glaucoma	1.44e-06	0.00118	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.41e-06	0.00115	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.41e-06	0.00115	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CA1—glaucoma	1.41e-06	0.00115	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RPTOR—glaucoma	1.38e-06	0.00113	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CA1—glaucoma	1.37e-06	0.00112	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CTSA—glaucoma	1.36e-06	0.00111	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NCK2—glaucoma	1.34e-06	0.00109	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CTSA—glaucoma	1.33e-06	0.00109	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.33e-06	0.00108	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CA1—glaucoma	1.29e-06	0.00106	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CA2—glaucoma	1.29e-06	0.00105	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CA1—glaucoma	1.28e-06	0.00105	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.26e-06	0.00103	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.26e-06	0.00103	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CA2—glaucoma	1.26e-06	0.00102	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.26e-06	0.00102	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CTSA—glaucoma	1.25e-06	0.00102	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CTSA—glaucoma	1.24e-06	0.00101	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CA2—glaucoma	1.18e-06	0.000966	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CA2—glaucoma	1.17e-06	0.000957	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.15e-06	0.000936	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.15e-06	0.000936	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HDAC9—glaucoma	1.14e-06	0.000927	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—EDN1—glaucoma	1.09e-06	0.000892	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.04e-06	0.000852	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TXN—glaucoma	1.02e-06	0.000829	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EDN1—glaucoma	9.93e-07	0.00081	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—C3—glaucoma	9.55e-07	0.000779	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.27e-07	0.000756	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.19e-07	0.000749	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TXN—glaucoma	9.07e-07	0.00074	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.95e-07	0.00073	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SMO—glaucoma	8.9e-07	0.000726	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TXN—glaucoma	8.85e-07	0.000722	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—C3—glaucoma	8.68e-07	0.000708	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CA1—glaucoma	8.46e-07	0.00069	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TXN—glaucoma	8.34e-07	0.00068	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.28e-07	0.000675	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TXN—glaucoma	8.27e-07	0.000675	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.2e-07	0.000669	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CTSA—glaucoma	8.2e-07	0.000669	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NTRK2—glaucoma	8.14e-07	0.000664	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.89e-07	0.000643	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTT1—glaucoma	7.88e-07	0.000643	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CA2—glaucoma	7.74e-07	0.000631	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.55e-07	0.000615	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.48e-07	0.00061	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTT1—glaucoma	7.03e-07	0.000574	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NGFR—glaucoma	6.98e-07	0.000569	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTT1—glaucoma	6.86e-07	0.00056	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NTRK1—glaucoma	6.63e-07	0.000541	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTT1—glaucoma	6.47e-07	0.000528	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTT1—glaucoma	6.41e-07	0.000523	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.35e-07	0.000518	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1B1—glaucoma	6.28e-07	0.000512	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCA1—glaucoma	6.28e-07	0.000512	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN2B—glaucoma	6.11e-07	0.000499	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EDN1—glaucoma	5.87e-07	0.000478	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.67e-07	0.000463	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCA1—glaucoma	5.6e-07	0.000457	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1B1—glaucoma	5.6e-07	0.000457	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1B1—glaucoma	5.47e-07	0.000446	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ABCA1—glaucoma	5.47e-07	0.000446	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TXN—glaucoma	5.45e-07	0.000445	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NGF—glaucoma	5.39e-07	0.00044	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.17e-07	0.000422	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCA1—glaucoma	5.15e-07	0.00042	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1B1—glaucoma	5.15e-07	0.00042	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—C3—glaucoma	5.12e-07	0.000418	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1B1—glaucoma	5.11e-07	0.000417	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCA1—glaucoma	5.11e-07	0.000417	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—glaucoma	5.02e-07	0.000409	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOE—glaucoma	4.77e-07	0.000389	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CAV1—glaucoma	4.73e-07	0.000386	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FN1—glaucoma	4.5e-07	0.000367	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—glaucoma	4.48e-07	0.000365	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BAD—glaucoma	4.45e-07	0.000363	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—glaucoma	4.44e-07	0.000362	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—glaucoma	4.37e-07	0.000357	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—glaucoma	4.23e-07	0.000345	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOE—glaucoma	4.13e-07	0.000337	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—glaucoma	4.12e-07	0.000336	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAV1—glaucoma	4.09e-07	0.000334	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—glaucoma	4.08e-07	0.000333	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—glaucoma	3.96e-07	0.000323	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—glaucoma	3.86e-07	0.000315	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOE—glaucoma	3.69e-07	0.000301	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAV1—glaucoma	3.65e-07	0.000298	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—glaucoma	3.64e-07	0.000297	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—glaucoma	3.61e-07	0.000294	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOE—glaucoma	3.6e-07	0.000293	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOS3—glaucoma	3.57e-07	0.000292	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAV1—glaucoma	3.56e-07	0.000291	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOE—glaucoma	3.39e-07	0.000276	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCA1—glaucoma	3.37e-07	0.000275	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1B1—glaucoma	3.37e-07	0.000275	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOE—glaucoma	3.36e-07	0.000274	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAV1—glaucoma	3.36e-07	0.000274	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAV1—glaucoma	3.33e-07	0.000272	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1B—glaucoma	3.1e-07	0.000253	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NOS3—glaucoma	3.09e-07	0.000252	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—glaucoma	2.87e-07	0.000234	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—glaucoma	2.83e-07	0.000231	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NOS3—glaucoma	2.76e-07	0.000225	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NOS3—glaucoma	2.7e-07	0.00022	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—glaucoma	2.69e-07	0.00022	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—glaucoma	2.58e-07	0.00021	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NOS3—glaucoma	2.54e-07	0.000207	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—glaucoma	2.53e-07	0.000206	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NOS3—glaucoma	2.52e-07	0.000205	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—glaucoma	2.46e-07	0.000201	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—glaucoma	2.38e-07	0.000194	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—glaucoma	2.32e-07	0.000189	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—glaucoma	2.3e-07	0.000188	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOE—glaucoma	2.22e-07	0.000181	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAV1—glaucoma	2.2e-07	0.000179	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—glaucoma	1.95e-07	0.000159	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NOS3—glaucoma	1.66e-07	0.000135	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—glaucoma	1.52e-07	0.000124	CbGpPWpGaD
